To Study Effect of Krishna Tila Churna in Menstrual Cramps.

A Randomised Controlled Clinical Study To Evaluate the Efficacy of Krishna Tila Churna in the Management of Udavartani Yonivyapad(Primary Dysmenorrhea) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102292

Enrollment

Registered

2026-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects of age between 15 to 35 years. 2 Subjects complaining painful menstruation for atleast 2 consecutive cycle. 3 Signs and symptoms of Udavartini yonivyapad (primary dysmenorrhea). 4 Subjects willing to sign the consent form.

Exclusion criteria

Exclusion criteria: 1 Known case of fibroid uterus, Menorrhagia, Endometriosis, Adenomyosis. 2 Known case of diseases like DM, HTN, Thyroid, PCOD and malignancy. 3 Known case of Congenital Anamolies.

Design outcomes

Primary

Measure	Time frame
Effect of trial drug on improvement in classical symptoms of UDAVARTINI YONIVYAPAD (PRIMARY DYSMENORRHEA) Timepoint: 1st Menstrual Cycle-1st day,5th day 2nd Menstrual Cycle-1st day,5th day 3rd Menstrual Cycle- 1st day,5th day	—

Secondary

Measure	Time frame
Safety of the trial drug and adverse drug reaction and aggravation in the symptoms of UDAVARTINI YONIVYAPAD (PRIMARY DYSMENORRHEA) Timepoint: 1st Menstrual Cycle-1st day,5th day 2nd Menstrual Cycle-1st day,5th day 3rd Menstrual Cycle- 1st day,5th day	—

Countries

India

Contacts

Public ContactDr Siddhi Vilas Mandavkar

SDMTs AMC Post Graduation Centre Terdal

drsukanyapatil@gmail.com9113611554

Outcome results